COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

Major coagulation disorders and parameters in COVID-19 patients

A Teimury, MT Khameneh, EM Khaledi - European journal of medical …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), with a high prevalence rate, has rapidly
infected millions of people around the world. Since viral infections can disrupt the …

Prognostic nutritional index, controlling nutritional status (CONUT) score, and inflammatory biomarkers as predictors of deep vein thrombosis, acute pulmonary …

AV Mureșan, I Hălmaciu, EM Arbănași, R Kaller… - Diagnostics, 2022 - mdpi.com
Background: Numerous tools, including nutritional and inflammatory markers, have been
evaluated as the predictors of poor outcomes in COVID-19 patients. This study aims to verify …

COVID-19 pneumonia imaging follow-up: when and how? A proposition from ESTI and ESR

K Martini, AR Larici, MP Revel, B Ghaye… - European …, 2021 - Springer
This document from the European Society of Thoracic Imaging (ESTI) and the European
Society of Radiology (ESR) discusses the role of imaging in the long-term follow-up of …

The long term residual effects of COVID-associated coagulopathy

M Ranucci, E Baryshnikova, M Anguissola… - International Journal of …, 2023 - mdpi.com
During the acute phase of COVID-19, many patients experience a complex coagulopathy
characterized by a procoagulant pattern. The present study investigates the persistence of …

What level of D-dimers can safely exclude pulmonary embolism in COVID-19 patients presenting to the emergency department?

MP Revel, N Beeker, R Porcher, L Jilet, L Fournier… - European …, 2022 - Springer
Objectives To identify which level of D-dimer would allow the safe exclusion of pulmonary
embolism (PE) in COVID-19 patients presenting to the emergency department (ED) …

[HTML][HTML] D‐dimer testing in clinical practice in the era of COVID‐19

C Auditeau, L Khider, B Planquette, O Sanchez… - Research and Practice …, 2022 - Elsevier
D‐dimer is a fragment of crosslinked fibrin resulting from plasmin cleavage of fibrin clots and
hence an indirect biomarker of the hemostatic system activation. Early in the coronavirus …

Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: results from a Spanish multicenter registry (BIOCOVID-Spain study)

L Garcia de Guadiana-Romualdo… - Journal of Thrombosis …, 2022 - Springer
Coagulopathy is a key feature of COVID-19 and D-dimer has been reported as a predictor of
severity. However, because D-dimer test results vary considerably among assays, resolving …

Increased Circulating CD62E+ Endothelial Extracellular Vesicles Predict Severity and in- Hospital Mortality of COVID-19 Patients

F Mezine, CL Guerin, A Philippe, N Gendron… - Stem Cell Reviews and …, 2023 - Springer
COVID-19 and infectious diseases have been included in strategic development goals
(SDG) of United Nations (UN). Severe form of COVID-19 has been described as an …

Intermediate-vs. standard-dose prophylactic anticoagulation in patients with COVID-19 admitted in medical ward: a propensity score-matched cohort study

DM Smadja, G Bonnet, N Gendron, O Weizman… - Frontiers in …, 2021 - frontiersin.org
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …